Don't miss more helpful resources about Boston Scientific’s Drug-Eluting Technologies in the Resources Center and join the Drug Eluting Technology Community to receive the latest news of Drug Eluting Technologies.
The Eluvia Stent is uniquely designed to deliver paclitaxel when restenosis is most likely to occur. Watch a video to learn how it works:
Discover how the Eluvia Stent was designed and engineered to solve the unique challenge of restenosis in the SFA. The only SFA stent to utilize polymer-based technology with proven biocompatibility—Eluvia sustains drug release beyond 12 months to match restenosis.
September 9, 2016